[HTML] frontiersin.org

[HTML][HTML] Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer

H Hu, S Tan, M Xie, P Guo, Q Yu, J Xiao… - Frontiers in …, 2023 - frontiersin.org
In non-small cell lung cancer (NSCLC), two key genetic alterations, epidermal growth factor
receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) rearrangements, are …
被引用次数：1 相关文章
[HTML] nih.gov

[HTML][HTML] Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer

H Hu, S Tan, M Xie, P Guo, Q Yu, J Xiao… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
In non-small cell lung cancer (NSCLC), two key genetic alterations, epidermal growth factor
receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) rearrangements, are …

Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer

H Hu, S Tan, M Xie, P Guo, Q Yu… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
In non-small cell lung cancer (NSCLC), two key genetic alterations, epidermal growth factor
receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) rearrangements, are …

Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer.

H Hu, S Tan, M Xie, P Guo, Q Yu, J Xiao… - Frontiers in …, 2023 - europepmc.org
In non-small cell lung cancer (NSCLC), two key genetic alterations, epidermal growth factor
receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) rearrangements, are …

[引用][C] Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer

H Hu, S Tan, M Xie, P Guo, Q Yu, J Xiao, K Zhao… - 2023 - europepmc.org
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for
approximately 80%-85% of cases (Zhou et al., 2021). In recent years, molecular genetics …